Skip to main content
. Author manuscript; available in PMC: 2015 Mar 1.
Published in final edited form as: Am J Gastroenterol. 2014 Jul 1;109(9):1304–1311. doi: 10.1038/ajg.2014.29

Table 1.

Baseline characteristics of Celiac and non-Celiac cohorts

CD HTN DM CHF ESRD GERD IBD IBS
Number of participants 341 75 69 41 18 61 67 37
Mean age, years (SE) 51.14 (0.81) 63.27 (1.37) 64.03 (1.31) 70.58 (2.07) 56.61 (4.27) 57.84 (1.62) 46.13 (1.90) 50.59 (0.81)
% Female, (SE) 76.26 (0.02) 45.95 (0.06) 38.24 (0.06) 53.66 (0.08) 44.44 (0.12) 40.00 (0.06) 46.97 (0.06) 52.78 (0.36)
% Caucasian, (SE) 96.77 (0.01) 80.00 (0.05) 70.59 (0.06) 68.29 (0.07) 61.11 (0.12) 77.96 (0.05) 93.73 (0.03) 88.89 (0.05)
% Income* < $75,000, (SE) 36.50 (0.03) 57.33 (0.06) 69.56 (0.06) 87.80 (0.05) 88.89 (0.08) 40.98 (0.06) 41.79 (0.06) 41.67 (0.08)
% No college education (SE) 26.71 (0.02) 48.00 (0.06) 56.52 (0.06) 56.10 (0.08) 66.67 (0.11) 42.62 (0.06) 28.36 (0.06) 30.56 (0.08)
Mean specialist visits/year (SE) 0.75 (0.03) 0.48 (0.12) 1.65 (0.21) 2.34 (0.23) 4.39 (0.24) 1.26 (0.21) 2.51 (0.17) 1.82 (0.24)
Mean PCP visits/year (SE) 2.19 (0.08) 2.54 (0.16) 3.13 (0.18) 3.61 (0.24) 3.28 (0.36) 2.60 (0.16) 2.18 (0.18) 2.85 (0.28)

CD, Celiac disease; HTN, Hypertension; DM, Diabetes Mellitus; CHF, Congestive heart failure; ESRD, End-stage renal disease; GERD, gastroesophageal reflux disease; IBD, inflammatory bowel disease; IBS, irritable bowel syndrome

SE, standard error

*

Income in US dollars